Please complete the CAPTCHA to continue
@xmarkfunds.com
✓
2 phones found area 203 and 718
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Cavalier is listed as Chief Financial Officer and Chief Operating Officer at Infusyn Therapeutics,LLC. at Infusyn Therapeutics, LLC, based in New York, United States. AeroLeads shows a work email signal at xmarkfunds.com, phone signal with area code 203, 718, and a matched LinkedIn profile for David Cavalier.
David Cavalier previously worked as Chief Financial Officer and Chief Operating Officer at Infusyn Therapeutics, Llc and Chief Financial Officer and Chief Operating Officer at Introsyn Therapeutics, Inc.. David Cavalier holds M.Phil from University Of Oxford.
This section adds company-level context without repeating David Cavalier's masked contact details.
AeroLeads found 2 current-domain work email signals for David Cavalier. Compare company email patterns before reaching out.
Experienced Owner, Operator and Director with a demonstrated history of working in the biotechnology industry. Strong entrepreneurship professional skilled in Biotechnology, Technology Transfer, Corporate Finance, Life Sciences, and Mergers & Acquisitions.
Listed skills include Venture Capital, Biotechnology, Mergers And Acquisitions, Financial Modeling, and 13 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New York, New York, United States
Infusyn Therapeutics markets the Prometra II pump, the most sophisticated implantable, programmable drug delivery pump on the market.
New York, New York, United States
New York, Ny
San Jose, California
Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed. We are developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs to treat ovarian cancer and other solid tumors. We are also developing the Cchek™ platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body’s immune response to the presence of a malignancy.
Quick answers generated from the profile data available on this page.
David Cavalier works for Infusyn Therapeutics, LLC.
David Cavalier is listed as Chief Financial Officer and Chief Operating Officer at Infusyn Therapeutics,LLC. at Infusyn Therapeutics, LLC.
AeroLeads has found 2 work email signals at @xmarkfunds.com for David Cavalier at Infusyn Therapeutics, LLC.
AeroLeads has found 2 phone signal(s) with area code 203, 718 for David Cavalier at Infusyn Therapeutics, LLC.
David Cavalier is based in New York, United States while working with Infusyn Therapeutics, LLC.
David Cavalier has worked for Infusyn Therapeutics, Llc, Introsyn Therapeutics, Inc., Mab & Stoke, Inc., Anixa Biosciences, and Xmark Opportunity Partners, Llc.
You can use AeroLeads to view verified contact signals for David Cavalier at Infusyn Therapeutics, LLC, including work email, phone, and LinkedIn data when available.
David Cavalier holds M.Phil from University Of Oxford.
David Cavalier is listed with skills including Venture Capital, Biotechnology, Mergers And Acquisitions, Financial Modeling, Due Diligence, Lifesciences, Life Sciences, and Start Ups.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the David Cavalier you were looking for.
